- Home
- CMPX vs GRX Comparison
CMPX vs GRX Comparison
Compare CMPX & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- GRX
- Stock Information
- Founded
- CMPX 2014
- GRX 2007
- Country
- CMPX United States
- GRX United States
- Employees
- CMPX N/A
- GRX N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- GRX Finance/Investors Services
- Sector
- CMPX Health Care
- GRX Finance
- Exchange
- CMPX Nasdaq
- GRX Nasdaq
- Market Cap
- CMPX 217.4M
- GRX 160.8M
- IPO Year
- CMPX N/A
- GRX N/A
- Fundamental
- Price
- CMPX $1.71
- GRX $11.06
- Analyst Decision
- CMPX Strong Buy
- GRX
- Analyst Count
- CMPX 3
- GRX 0
- Target Price
- CMPX $7.67
- GRX N/A
- AVG Volume (30 Days)
- CMPX 381.5K
- GRX 39.7K
- Earning Date
- CMPX 11-07-2024
- GRX 01-01-0001
- Dividend Yield
- CMPX N/A
- GRX 5.98%
- EPS Growth
- CMPX N/A
- GRX N/A
- EPS
- CMPX N/A
- GRX 0.26
- Revenue
- CMPX $850,000.00
- GRX N/A
- Revenue This Year
- CMPX N/A
- GRX N/A
- Revenue Next Year
- CMPX $950.68
- GRX N/A
- P/E Ratio
- CMPX N/A
- GRX $38.50
- Revenue Growth
- CMPX N/A
- GRX N/A
- 52 Week Low
- CMPX $0.77
- GRX $7.73
- 52 Week High
- CMPX $2.34
- GRX $10.40
- Technical
- Relative Strength Index (RSI)
- CMPX 68.40
- GRX 64.50
- Support Level
- CMPX $1.42
- GRX $11.01
- Resistance Level
- CMPX $1.65
- GRX $11.20
- Average True Range (ATR)
- CMPX 0.14
- GRX 0.12
- MACD
- CMPX 0.02
- GRX -0.03
- Stochastic Oscillator
- CMPX 77.43
- GRX 73.08
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.